Pulmicort CFC-free range

In line with the global phase-out of chlorofluorocarbon (CFC)-containing inhalers in favour of inhalers that use more environmentally friendly CFC-free propellants, AstraZeneca has launched Pulmicort (budesonide) 200 microgram CFC-free metered dose inhaler (MDI).

This is the latest addition to the company's range of CFC-free MDIs, which includes the Pulmicort 100 microgram CFC-free MDI.

View Pulmicort CFC-free drug record

Further information: AstraZeneca

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New information pack guides GPs on best practice management of constipation

New information pack guides GPs on best practice management of constipation

Published by the Bowel Interest Group (BIG), the pack...

Drug shortages - live tracker

Drug shortages - live tracker

Added: calcium chloride, oily phenol, Physeptone and...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Antibiotic Treatments in Adults, Summary of Regimens

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.